Test Your Knowledge of HCC Presented at ASCO 2024!
Do you remember the HCC research presented at ASCO 2024? Test your knowledge and see how you rank!
Do you remember the HCC research presented at ASCO 2024? Test your knowledge and see how you rank!
A curated eBook featuring ASCO 2024 HCC-focused studies, findings, and expert opinions.
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Black patients with HCC are less likely than White patients to receive curative treatment.
While patients with hepatocellular carcinoma largely felt independent, their caregivers reported burdens related to appointment logistics and emotional support.
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
The following is a summary of “Survival outcomes with adjuvant immunotherapy after hepatic...
The following is a summary of “Identification of a predictive phosphoproteomic signature of...
The following is a summary of “Identification of molecular subtypes for integrated multi-omics...
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.